Get a glimpse into our company and investor data—powered by the PitchBook Platform
GrantLATEST DEAL TYPE
$252KLATEST DEAL AMOUNT
Developer of cancer screening tests. The company is an early stage bio-tech enterprise developing screening tests focused on infection-related cancers such as hepatitis B virus (HBV)-induced liver cancer.